Home » Topics » Regulatory

Regulatory
RSS

Remicade approved in U.S. for new indication

Sep. 26, 2011

Avastin approved for new indication in Japan

Sep. 26, 2011

European approval of Removab broadened

Sep. 21, 2011

FDA approves Prolia for new indications

Sep. 20, 2011

Ono Pharmaceutical secures new Japanese approval for Glactiv

Sep. 19, 2011

Vibativ approved in Europe

Sep. 15, 2011

Ono Pharmaceutical set to launch Corebeta in Japan

Sep. 14, 2011

Novartis gains E.U. approval for Votubia

Sep. 8, 2011

European Commission grants PUMA for Buccolam

Sep. 7, 2011

FDA expands indication of Baxter's Artiss

Sep. 6, 2011

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 10, 2025
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...